Snakebite AI, Biosensors, and Game-Changing Partnerships + Call for Posters!

Hi ,

This week’s newsletter curates the latest advancements and opportunities defining synthetic biology’s trajectory. As applications for SynBioBeta 2025 digital poster sessions open, researchers are invited to share their breakthroughs with a global audience of peers and investors. Highlights include AI-designed proteins poised to revolutionize antivenom treatments, the extraordinary sensitivity of the ROSALIND 3.0 biosensor, and transformative strides in biomanufacturing and gene editing. With insights from leading minds and major funding announcements, this edition captures the pulse of innovation. Be part of the conversation shaping the future—SynBioBeta 2025 is just around the corner.

Enjoy your week!

Applications for SynBioBeta 2025 Digital Poster Sessions are now live!

This is a unique opportunity to showcase your innovative research to a global audience of researchers, entrepreneurs, and investors in synthetic biology. Share your breakthroughs, connect with key players in the field, and be part of the conversation shaping the future of biology. Abstract submissions are due March 17.

The Future of Biology Starts Here: Welcoming Our Latest SynBioBeta Speakers

Don’t miss your chance to hear from the brightest minds in the industry. Secure your spot for SynBioBeta 2025 today!

Check Out Our Latest Sponsors and Exhibitors for SynBioBeta 2025!

AI Takes a Bite Out of Snake Venom

A new study by this year's Nobel Laureate in Chemistry reveals that AI-designed proteins may revolutionize how we treat snakebites, offering safer and more effective alternatives to traditional antivenoms and providing broader implications for other medical treatments.

Pump Up The Volume: ROSALIND 3.0 is Set to Revolutionize Biosensing

Northwestern scientists have developed a biosensor capable of detecting faint molecular signals with unprecedented sensitivity, revolutionizing health and environmental monitoring.